mHSPC: Use of Triplet Therapy
Experts in prostate cancer consider patient suitability for triplet therapy in the setting of metastatic hormone-sensitive disease.
Source: onclive.com
Stay updated with breaking news from Chaarted Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Experts in prostate cancer consider patient suitability for triplet therapy in the setting of metastatic hormone-sensitive disease.
A focused review of patient and disease factors that inform selection of therapy for patients with metastatic hormone-sensitive prostate cancer.